AR242716A1 - Procedimiento para la preparacion de una composicion para la administracion de drogas hidrofugas. - Google Patents

Procedimiento para la preparacion de una composicion para la administracion de drogas hidrofugas.

Info

Publication number
AR242716A1
AR242716A1 AR86305237A AR30523786A AR242716A1 AR 242716 A1 AR242716 A1 AR 242716A1 AR 86305237 A AR86305237 A AR 86305237A AR 30523786 A AR30523786 A AR 30523786A AR 242716 A1 AR242716 A1 AR 242716A1
Authority
AR
Argentina
Prior art keywords
parenteral
oral administration
water soluble
emulsion compositions
hydrophobic drugs
Prior art date
Application number
AR86305237A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of AR242716A1 publication Critical patent/AR242716A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AR86305237A 1985-09-16 1986-09-15 Procedimiento para la preparacion de una composicion para la administracion de drogas hidrofugas. AR242716A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/776,306 US4784845A (en) 1985-09-16 1985-09-16 Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs

Publications (1)

Publication Number Publication Date
AR242716A1 true AR242716A1 (es) 1993-05-31

Family

ID=25107019

Family Applications (1)

Application Number Title Priority Date Filing Date
AR86305237A AR242716A1 (es) 1985-09-16 1986-09-15 Procedimiento para la preparacion de una composicion para la administracion de drogas hidrofugas.

Country Status (18)

Country Link
US (1) US4784845A (es)
EP (1) EP0215313B1 (es)
JP (1) JPS6267018A (es)
KR (1) KR890004684B1 (es)
AR (1) AR242716A1 (es)
AT (1) ATE78683T1 (es)
AU (1) AU591705B2 (es)
CA (1) CA1272447A (es)
DE (1) DE3686221T2 (es)
DK (1) DK165730C (es)
ES (1) ES2002750A6 (es)
FI (1) FI863728A (es)
GR (1) GR862354B (es)
HU (1) HU199282B (es)
NO (1) NO863670L (es)
NZ (1) NZ217484A (es)
PH (1) PH23736A (es)
ZA (1) ZA867009B (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
US4820724A (en) * 1986-03-31 1989-04-11 University Of Southern California Dual phase solvent carrier system
GB8714652D0 (en) * 1987-06-23 1987-07-29 Davis S S Drug emulsion
US5229422A (en) * 1987-09-07 1993-07-20 Teijin Limited Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion
NZ227813A (en) * 1988-02-10 1990-03-27 Richardson Vicks Inc Oil in water emulsion having 3-40% oil and an amphipathic emulsifying agent in the range 0.02-2% and method of forming such emulsions
AU622664B2 (en) * 1988-03-21 1992-04-16 Daratech Pty Ltd Teat dip
EP0406275A4 (en) * 1988-03-21 1992-05-06 Daratech Pty. Ltd. Teat dip
US5338761A (en) * 1988-09-29 1994-08-16 Shiseido Company Ltd. Emulsified composition
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
US5004593A (en) * 1989-04-17 1991-04-02 Mayo Foundation For Medical Education And Research Hexamethylmelamine formulation exhibiting reduced neurotoxicity
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
WO1992007571A1 (fr) * 1990-11-06 1992-05-14 Nippon Shinyaku Co., Ltd. Procede de production d'une emulsion grasse
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
IL103275A0 (en) * 1991-10-01 1993-02-21 Lilly Co Eli Injectable extended release formulations and methods
JPH06245700A (ja) * 1993-02-23 1994-09-06 Snow Brand Milk Prod Co Ltd 消化吸収性を低減した油脂組成物
WO1994028872A1 (en) * 1993-06-04 1994-12-22 Warner-Lambert Company Non-alcoholic cold and sinus medication
AU691248B2 (en) * 1994-02-04 1998-05-14 Scotia Lipidteknik Ab Oil-in-water emulsions
CA2182698A1 (en) * 1994-02-25 1995-08-31 Jun Sato Injectable emulsions containing antifungal triazole derivatives
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
ATE333867T1 (de) * 1994-03-18 2006-08-15 Shire Lab Inc Emulgierte arzneistoffabgabesysteme
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
EP0873127B1 (en) * 1995-09-25 2006-11-15 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE69725745D1 (de) 1996-06-05 2003-11-27 Ashmont Holdings Ltd Injizierbare zusammensetzungen
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
CZ300725B6 (cs) * 1997-09-30 2009-07-29 Eli Lilly And Company 2-Methylthienbenzodiazepinová formulace
US6036946A (en) * 1997-12-24 2000-03-14 Shaklee Corporation Methods for protecting skin from damaging effects of ultraviolet light
WO1999043301A1 (en) * 1998-02-24 1999-09-02 The Board Of Trustees Of The University Of Illinois Lipid emulsions in the treatment of systemic poisoning
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6146664A (en) * 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
US6777450B1 (en) * 2000-05-26 2004-08-17 Color Access, Inc. Water-thin emulsions with low emulsifier levels
EP1461044A4 (en) * 2001-12-03 2007-06-13 Novacea Inc PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE COMPOUNDS OF VITAMIN D
WO2003057128A2 (en) * 2001-12-11 2003-07-17 Dor Biopharma, Inc. Lipid particles and suspensions and uses thereof
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040062779A1 (en) * 2002-09-26 2004-04-01 Jerry Whittemore Dermatologic composition using ultra-fine/micronized 1-ascorbic acid and other antioxidant ingredients in a stabilized anhydrous vehicle
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
US20050186230A1 (en) * 2004-01-23 2005-08-25 Sd Pharmaceuticals, Inc. Elemene compositions containing liquid oil
PT1838716E (pt) 2005-01-05 2011-07-15 Lilly Co Eli Di-hidrato de pamoato de olanzapina
US8685455B2 (en) 2005-03-31 2014-04-01 Suntory Holdings Limited Oil-in-water emulsions containing lignan-class compounds and compositions containing the same
EP1957053A4 (en) * 2005-11-17 2012-03-28 Bioavailability Inc BIOKOMPATIBLE LATENT EMULSIFICATORS
EP2070532B1 (en) * 2006-10-04 2013-07-24 Suntory Holdings Limited O/w/o emulsion containing lignan compounds, and composition containing the same
WO2009042114A2 (en) 2007-09-21 2009-04-02 The Johns Hopkins University Phenazine derivatives and uses thereof
US20100022469A1 (en) * 2008-06-24 2010-01-28 Majid Razzak Anthelminthic formulations
KR20160099081A (ko) 2013-07-26 2016-08-19 업데이트 파마 인코포레이트 비산트렌의 치료 효과 개선용 조합 방법
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
CA3073527A1 (en) * 2017-09-12 2019-03-21 Academic Pharmaceuticals, Inc. Metolazone emulsion formulation
US20210401775A1 (en) * 2018-11-02 2021-12-30 Amaterasu Lifesciences Llp A liquid injectable composition

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3172816A (en) * 1963-01-28 1965-03-09 Smith Kline French Lab Method of increasing the oil solubility of compounds and products thereof
US3647624A (en) * 1969-07-24 1972-03-07 Wisconsin Alumni Res Found Treatment of blood with oleaginous substance
US4124720A (en) * 1970-11-09 1978-11-07 Wenmaekers Georges E J Therapeutic hydrodispersible emulsion
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
FR2313078A1 (fr) * 1975-02-07 1976-12-31 Anvar Composition a base d'huile vegetale metabolisable et d'eau, utilisable notamment pour la constitution de preparations adjuvantes, ces preparations adjuvantes et leur procede d'obtention
DE2526938C2 (de) * 1975-02-14 1982-04-22 F. Hoffmann-La Roche & Co. AG, 4002 Basel Vitaminpräparate
US3991206A (en) * 1976-01-15 1976-11-09 American Cyanamid Company Alleviation of eye inflammation by topical application of p-biphenylacetic acid
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
ES484296A1 (es) * 1978-09-22 1980-10-01 Unilever Nv Un procedimiento de preparacion de una emulsion de agua en aceite adecuados para la preparacion de cosmeticos, farma- cos y otros productos.
US4340054A (en) * 1980-12-29 1982-07-20 Alza Corporation Dispenser for delivering fluids and solids
GB2105589B (en) * 1981-09-11 1985-10-23 Wellcome Found Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent
JPS5859912A (ja) * 1981-10-06 1983-04-09 Green Cross Corp:The 鎮痛消炎物質脂肪乳剤
JPS59134710A (ja) * 1983-01-21 1984-08-02 Suntory Ltd 発酵養毛化粧料
US4563354A (en) * 1983-10-26 1986-01-07 Kabivitrum Ab Oil-in-water emulsion for parenteral administration
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs

Also Published As

Publication number Publication date
GR862354B (en) 1987-01-19
DK165730C (da) 1993-06-07
DE3686221T2 (de) 1993-02-25
ATE78683T1 (de) 1992-08-15
ZA867009B (en) 1987-07-29
HUT43947A (en) 1988-01-28
CA1272447A (en) 1990-08-07
DK165730B (da) 1993-01-11
ES2002750A6 (es) 1988-10-01
EP0215313B1 (en) 1992-07-29
AU6269686A (en) 1987-03-19
FI863728A (fi) 1987-03-17
NO863670L (no) 1987-03-17
JPS6267018A (ja) 1987-03-26
FI863728A0 (fi) 1986-09-15
NZ217484A (en) 1990-04-26
KR870002835A (ko) 1987-04-13
EP0215313A3 (en) 1987-09-09
NO863670D0 (no) 1986-09-15
DE3686221D1 (de) 1992-09-03
DK438286A (da) 1987-03-17
KR890004684B1 (ko) 1989-11-25
AU591705B2 (en) 1989-12-14
HU199282B (en) 1990-02-28
PH23736A (en) 1989-11-03
EP0215313A2 (en) 1987-03-25
DK438286D0 (da) 1986-09-12
US4784845A (en) 1988-11-15

Similar Documents

Publication Publication Date Title
AR242716A1 (es) Procedimiento para la preparacion de una composicion para la administracion de drogas hidrofugas.
GB2199031B (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
IL103748A (en) 2-substituted saccharin derivatives and pharmaceutical compositions containing them
GB2181346B (en) Pharmaceutical compositions and medical uses of dioxopiperidine derivatives
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ215186A (en) 13 alkoxymethoxy avermectin derivatives and pharmaceutical compositions
NZ218473A (en) Calcitonin derivatives and pharmaceutical compositions
NZ216951A (en) Pyrimidine derivatives and pharmaceutical compositions
IT1190282B (it) Composizioni di fenitoina per somministrazione parenterale e procedimento di preparazione
IL78336A (en) Compositions for delivery of orally administered fat-soluble drugs
NZ217342A (en) 4-amino-n-(alkyl n -p-benzamide derivatives and pharmaceutical compositions
NZ215871A (en) Fluorinated phenylalkyl-triazole derivatives and pharmaceutical compositions
IL79236A0 (en) Pharmaceutical compositions containing vitamin d derivatives
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
PT83188A (en) Process for the preparation of benzimidazole derivatives and of pharmaceutical compositions containing the same
PT83604A (en) Process for the preparation of flavone derivatives and of pharmaceutical compositions containing the same
NZ215362A (en) Pyrimidyl-substituted benzimidazole derivatives; pharmaceutical compositions and pyrimidine derivatives
IL79583A0 (en) Androsterone derivatives and pharmaceutical compositions containing the same
NZ218498A (en) Fluoroalkylamine derivatives and pharmaceutical compositions
NZ216720A (en) Diazinylpiperidine derivatives and pharmaceutical compositions
NZ216875A (en) 7-oxabicycloheptane derivatives and pharmaceutical compositions
NZ218098A (en) Imidazole derivatives and pharmaceutical compositions
NZ216546A (en) Glycerol derivatives and pharmaceutical compositions